These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 23216791

  • 1. Interplay between neural-cadherin and vascular endothelial-cadherin in breast cancer progression.
    Rezaei M, Friedrich K, Wielockx B, Kuzmanov A, Kettelhake A, Labelle M, Schnittler H, Baretton G, Breier G.
    Breast Cancer Res; 2012 Dec 06; 14(6):R154. PubMed ID: 23216791
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
    Labelle M, Schnittler HJ, Aust DE, Friedrich K, Baretton G, Vestweber D, Breier G.
    Cancer Res; 2008 Mar 01; 68(5):1388-97. PubMed ID: 18316602
    [Abstract] [Full Text] [Related]

  • 3. The expression of VE-cadherin in breast cancer cells modulates cell dynamics as a function of tumor differentiation and promotes tumor-endothelial cell interactions.
    Rezaei M, Cao J, Friedrich K, Kemper B, Brendel O, Grosser M, Adrian M, Baretton G, Breier G, Schnittler HJ.
    Histochem Cell Biol; 2018 Jan 01; 149(1):15-30. PubMed ID: 29143117
    [Abstract] [Full Text] [Related]

  • 4. Downregulation of β-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells.
    Cai K, Jiang L, Wang J, Zhang H, Wang X, Cheng D, Dou J.
    J Cancer Res Ther; 2014 Jan 01; 10(4):1063-70. PubMed ID: 25579555
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
    Hong KO, Kim JH, Hong JS, Yoon HJ, Lee JI, Hong SP, Hong SD.
    J Exp Clin Cancer Res; 2009 Feb 26; 28(1):28. PubMed ID: 19243631
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression.
    Miura N, Yano T, Shoji F, Kawano D, Takenaka T, Ito K, Morodomi Y, Yoshino I, Maehara Y.
    Anticancer Res; 2009 Oct 26; 29(10):4099-106. PubMed ID: 19846957
    [Abstract] [Full Text] [Related]

  • 7. The Influence of VE-Cadherin on Adhesion and Incorporation of Breast Cancer Cells into Vascular Endothelium.
    Brock T, Boudriot E, Klawitter A, Großer M, Nguyen TTP, Giebe S, Klapproth E, Temme A, El-Armouche A, Breier G.
    Int J Mol Sci; 2021 Jun 03; 22(11):. PubMed ID: 34205118
    [Abstract] [Full Text] [Related]

  • 8. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.
    Pati S, Khakoo AY, Zhao J, Jimenez F, Gerber MH, Harting M, Redell JB, Grill R, Matsuo Y, Guha S, Cox CS, Reitz MS, Holcomb JB, Dash PK.
    Stem Cells Dev; 2011 Jan 03; 20(1):89-101. PubMed ID: 20446815
    [Abstract] [Full Text] [Related]

  • 9. Endothelial cadherins in cancer.
    Breier G, Grosser M, Rezaei M.
    Cell Tissue Res; 2014 Mar 03; 355(3):523-7. PubMed ID: 24619142
    [Abstract] [Full Text] [Related]

  • 10. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
    Umbreit C, Flanjak J, Weiss C, Erben P, Aderhold C, Faber A, Stern-Straeter J, Hoermann K, Schultz JD.
    Anticancer Res; 2014 Dec 03; 34(12):7061-9. PubMed ID: 25503133
    [Abstract] [Full Text] [Related]

  • 11. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition.
    Yan W, Cao QJ, Arenas RB, Bentley B, Shao R.
    J Biol Chem; 2010 Apr 30; 285(18):14042-51. PubMed ID: 20189993
    [Abstract] [Full Text] [Related]

  • 12. The T box transcription factor TBX2 promotes epithelial-mesenchymal transition and invasion of normal and malignant breast epithelial cells.
    Wang B, Lindley LE, Fernandez-Vega V, Rieger ME, Sims AH, Briegel KJ.
    PLoS One; 2012 Apr 30; 7(7):e41355. PubMed ID: 22844464
    [Abstract] [Full Text] [Related]

  • 13. Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells.
    Sehrawat A, Singh SV.
    Cancer Prev Res (Phila); 2011 Jul 30; 4(7):1107-17. PubMed ID: 21464039
    [Abstract] [Full Text] [Related]

  • 14. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA, Palmer TD, Ashby WJ, Nashabi A, Chytil A, Aakre M, Pickup MW, Gorska AE, Zijlstra A, Moses HL.
    Breast Cancer Res; 2012 Jul 02; 14(4):R98. PubMed ID: 22748014
    [Abstract] [Full Text] [Related]

  • 15. The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells.
    Sahni A, Arévalo MT, Sahni SK, Simpson-Haidaris PJ.
    Int J Cancer; 2009 Aug 01; 125(3):577-84. PubMed ID: 19358279
    [Abstract] [Full Text] [Related]

  • 16. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.
    Thomas C, Rajapaksa G, Nikolos F, Hao R, Katchy A, McCollum CW, Bondesson M, Quinlan P, Thompson A, Krishnamurthy S, Esteva FJ, Gustafsson JÅ.
    Breast Cancer Res; 2012 Nov 16; 14(6):R148. PubMed ID: 23158001
    [Abstract] [Full Text] [Related]

  • 17. VE-Cadherin-Mediated Epigenetic Regulation of Endothelial Gene Expression.
    Morini MF, Giampietro C, Corada M, Pisati F, Lavarone E, Cunha SI, Conze LL, O'Reilly N, Joshi D, Kjaer S, George R, Nye E, Ma A, Jin J, Mitter R, Lupia M, Cavallaro U, Pasini D, Calado DP, Dejana E, Taddei A.
    Circ Res; 2018 Jan 19; 122(2):231-245. PubMed ID: 29233846
    [Abstract] [Full Text] [Related]

  • 18. Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes.
    Benzina S, Beauregard AP, Guerrette R, Jean S, Faye MD, Laflamme M, Maïcas E, Crapoulet N, Ouellette RJ, Robichaud GA.
    Oncotarget; 2017 Feb 14; 8(7):12052-12066. PubMed ID: 28076843
    [Abstract] [Full Text] [Related]

  • 19. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ, Gunasinghe NPAD, Hollier BG, Tanaka T, Blick T, Toh A, Hill P, Gilles C, Waltham M, Thompson EW.
    Breast Cancer Res; 2017 Jul 27; 19(1):86. PubMed ID: 28750639
    [Abstract] [Full Text] [Related]

  • 20. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
    Schäfer R, Abraham D, Paulus P, Blumer R, Grimm M, Wojta J, Aharinejad S.
    Circulation; 2003 Sep 30; 108(13):1585-91. PubMed ID: 12963640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.